Request Deal Involvement

BioMarin to acquire Amicus Therapeutics for $4.8bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Centerview Partners

financial advisors

Centerview Partners

Goldman Sachs

financial advisors

Goldman Sachs

Joele Frank

pr advisors

Joele Frank

Jones Day

legal advisors

Jones Day

Morgan Stanley

financial advisors

Morgan Stanley

JP Morgan

financial advisors

JP Morgan

Sullivan & Cromwell

legal advisors to financial advisors

Sullivan & Cromwell

Cooley

legal advisors to financial advisors

Cooley

or

Principals

AMICUS THERAPEUTICS

target

AMICUS THERAPEUTICS

BIOMARIN PHARMACEUTICAL

bidder

BIOMARIN PHARMACEUTICAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - BioMarin to acquire Amicus Therapeutics for $4.8bn.